• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于生物医学应用的光合共生

Photosymbiosis for Biomedical Applications.

作者信息

Chávez Myra N, Moellhoff Nicholas, Schenck Thilo L, Egaña José Tomás, Nickelsen Jörg

机构信息

Molecular Plant Science, Department Biology I, Ludwig-Maximilians-Universität München, Munich, Germany.

Division of Hand, Plastic and Aesthetic Surgery, University Hospital, Ludwig Maximilian Universität München, Munich, Germany.

出版信息

Front Bioeng Biotechnol. 2020 Oct 6;8:577204. doi: 10.3389/fbioe.2020.577204. eCollection 2020.

DOI:10.3389/fbioe.2020.577204
PMID:33123516
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7573207/
Abstract

Without the sustained provision of adequate levels of oxygen by the cardiovascular system, the tissues of higher animals are incapable of maintaining normal metabolic activity, and hence cannot survive. The consequence of this evolutionarily suboptimal design is that humans are dependent on cardiovascular perfusion, and therefore highly susceptible to alterations in its normal function. However, hope may be at hand. "Photosynthetic strategies," based on the recognition that photosynthesis is the source of all oxygen, offer a revolutionary and promising solution to pathologies related to tissue hypoxia. These approaches, which have been under development over the past 20 years, seek to harness photosynthetic microorganisms as a local and controllable source of oxygen to circumvent the need for blood perfusion to sustain tissue survival. To date, their applications extend from the creation of artificial human tissues to the photosynthetic maintenance of oxygen-deprived organs both and , while their potential use in other medical approaches has just begun to be explored. This review provides an overview of the state of the art of photosynthetic technologies and its innovative applications, as well as an expert assessment of the major challenges and how they can be addressed.

摘要

如果心血管系统不能持续提供足够水平的氧气,高等动物的组织就无法维持正常的代谢活动,因而无法存活。这种在进化上并非最优的设计所带来的后果是,人类依赖心血管灌注,因此极易受到其正常功能改变的影响。然而,希望或许就在眼前。基于光合作用是所有氧气来源这一认识的“光合策略”,为与组织缺氧相关的病症提供了一种革命性的、有前景的解决方案。这些方法在过去20年中一直在研发,旨在利用光合微生物作为局部且可控的氧气来源,从而无需血液灌注来维持组织存活。迄今为止,它们的应用范围从人造人体组织的创建到对缺氧器官的光合维持,涵盖了体内和体外,而它们在其他医学方法中的潜在用途才刚刚开始被探索。这篇综述概述了光合技术的现状及其创新应用,以及对主要挑战及其应对方法的专家评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2713/7573207/97dfbe9de7c5/fbioe-08-577204-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2713/7573207/2a693f12aa4b/fbioe-08-577204-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2713/7573207/97dfbe9de7c5/fbioe-08-577204-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2713/7573207/2a693f12aa4b/fbioe-08-577204-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2713/7573207/97dfbe9de7c5/fbioe-08-577204-g002.jpg

相似文献

1
Photosymbiosis for Biomedical Applications.用于生物医学应用的光合共生
Front Bioeng Biotechnol. 2020 Oct 6;8:577204. doi: 10.3389/fbioe.2020.577204. eCollection 2020.
2
New trends in biotechnological applications of photosynthetic microorganisms.光合作用微生物生物技术应用的新趋势。
Biotechnol Adv. 2022 Oct;59:107988. doi: 10.1016/j.biotechadv.2022.107988. Epub 2022 May 21.
3
Development of a Novel Perfusable Solution for Preservation: Towards Photosynthetic Oxygenation for Organ Transplantation.一种新型可灌注保存溶液的研发:迈向用于器官移植的光合氧合作用
Front Bioeng Biotechnol. 2021 Dec 15;9:796157. doi: 10.3389/fbioe.2021.796157. eCollection 2021.
4
Towards autotrophic tissue engineering: Photosynthetic gene therapy for regeneration.迈向自养组织工程:光合作用基因治疗的再生应用。
Biomaterials. 2016 Jan;75:25-36. doi: 10.1016/j.biomaterials.2015.10.014. Epub 2015 Oct 8.
5
Photosynthetic biomaterials: a pathway towards autotrophic tissue engineering.光合生物材料:通向自养组织工程的途径。
Acta Biomater. 2015 Mar;15:39-47. doi: 10.1016/j.actbio.2014.12.012. Epub 2014 Dec 20.
6
Development of photosynthetic sutures for the local delivery of oxygen and recombinant growth factors in wounds.用于伤口局部递送氧气和重组生长因子的光合缝线的研制。
Acta Biomater. 2018 Nov;81:184-194. doi: 10.1016/j.actbio.2018.09.060. Epub 2018 Oct 1.
7
Development of photosynthetic biomaterials for in vitro tissue engineering.用于体外组织工程的光合生物材料的开发。
Acta Biomater. 2014 Jun;10(6):2712-7. doi: 10.1016/j.actbio.2013.12.055. Epub 2014 Jan 7.
8
Continuous cultivation of photosynthetic microorganisms: Approaches, applications and future trends.连续培养光合微生物:方法、应用和未来趋势。
Biotechnol Adv. 2015 Nov 1;33(6 Pt 2):1228-45. doi: 10.1016/j.biotechadv.2015.03.004. Epub 2015 Mar 14.
9
[Cyanobacteria based photosynthetic production of sucrose: development and prospect].[基于蓝藻的蔗糖光合生产:进展与展望]
Sheng Wu Gong Cheng Xue Bao. 2019 Aug 25;35(8):1411-1423. doi: 10.13345/j.cjb.190026.
10
Engineering photosynthesis in plants and synthetic microorganisms.在植物和合成微生物中进行光合作用工程。
J Exp Bot. 2013 Jan;64(3):743-51. doi: 10.1093/jxb/ers263. Epub 2012 Oct 1.

引用本文的文献

1
Bioactivated scaffolds promote angiogenesis and lymphangiogenesis for dermal regeneration in vivo.生物活性支架可促进体内真皮再生的血管生成和淋巴管生成。
J Tissue Eng. 2025 Mar 12;16:20417314251317542. doi: 10.1177/20417314251317542. eCollection 2025 Jan-Dec.
2
Towards chlorocytes for therapeutic intravascular photosynthesis.迈向用于治疗性血管内光合作用的含氯细胞。
Appl Microbiol Biotechnol. 2024 Oct 17;108(1):489. doi: 10.1007/s00253-024-13285-1.
3
Processed microalgae: green gold for tissue regeneration and repair.微藻加工:组织再生和修复的绿色黄金。

本文引用的文献

1
Immune-modulatory alginate protects mesenchymal stem cells for sustained delivery of reparative factors to ischemic myocardium.免疫调节性海藻酸盐保护间充质干细胞,以持续向缺血心肌递送修复因子。
Biomater Sci. 2020 Sep 15;8(18):5061-5070. doi: 10.1039/d0bm00855a.
2
Engineered algae: A novel oxygen-generating system for effective treatment of hypoxic cancer.工程藻类:一种新型供氧系统,可有效治疗缺氧性癌症。
Sci Adv. 2020 May 20;6(21):eaba5996. doi: 10.1126/sciadv.aba5996. eCollection 2020 May.
3
Safety of photosynthetic Synechococcus elongatus for in vivo cyanobacteria-mammalian symbiotic therapeutics.
Theranostics. 2024 Aug 19;14(13):5235-5261. doi: 10.7150/thno.99181. eCollection 2024.
4
Hypoxic environment of wounds and photosynthesis-based oxygen therapy.伤口的缺氧环境与基于光合作用的氧疗
Burns Trauma. 2024 Jun 10;12:tkae012. doi: 10.1093/burnst/tkae012. eCollection 2024.
5
Biocompatibility of sp. PCC 7002 with Human Dermal Cells In Vitro.与人体真皮细胞的体外生物相容性。
Int J Mol Sci. 2024 Mar 31;25(7):3922. doi: 10.3390/ijms25073922.
6
Adipose-Derived Stem Cells Improve Angiogenesis and Lymphangiogenesis in a Hypoxic Dermal Regeneration Model In Vitro.脂肪来源干细胞在体外低氧皮肤再生模型中促进血管生成和淋巴管生成。
Medicina (Kaunas). 2023 Apr 4;59(4):706. doi: 10.3390/medicina59040706.
7
The use of commercial fibrin glue in dermal replacement material reduces angiogenic and lymphangiogenic gene and protein expression in vitro.商用纤维蛋白胶在真皮替代物中的应用减少了体外的血管生成和淋巴管生成基因及蛋白表达。
J Biomater Appl. 2023 May;37(10):1858-1873. doi: 10.1177/08853282231171681. Epub 2023 Apr 21.
8
Case report: Long-term follow-up of a large full-thickness skin defect treated with a photosynthetic scaffold for dermal regeneration.病例报告:用光合支架治疗全层皮肤大面积缺损以促进真皮再生的长期随访
Front Bioeng Biotechnol. 2022 Dec 1;10:1004155. doi: 10.3389/fbioe.2022.1004155. eCollection 2022.
9
Towards an In Vitro 3D Model for Photosynthetic Cancer Treatment: A Study of Microalgae and Tumor Cell Interactions.用于光合癌症治疗的体外 3D 模型:微藻与肿瘤细胞相互作用的研究。
Int J Mol Sci. 2022 Nov 4;23(21):13550. doi: 10.3390/ijms232113550.
10
Light-Driven Synthetic Biology: Progress in Research and Industrialization of Cyanobacterial Cell Factory.光驱动合成生物学:蓝藻细胞工厂的研究与产业化进展
Life (Basel). 2022 Oct 3;12(10):1537. doi: 10.3390/life12101537.
光合聚球藻用于体内蓝细菌-哺乳动物共生治疗的安全性。
Microb Biotechnol. 2020 Nov;13(6):1780-1792. doi: 10.1111/1751-7915.13596. Epub 2020 May 31.
4
Dissolved oxygen from microalgae-gel patch promotes chronic wound healing in diabetes.微藻凝胶贴片中的溶解氧促进糖尿病慢性伤口愈合。
Sci Adv. 2020 May 15;6(20):eaba4311. doi: 10.1126/sciadv.aba4311. eCollection 2020 May.
5
Current advances in the algae-made biopharmaceuticals field.藻类生物制药领域的最新进展。
Expert Opin Biol Ther. 2020 Jul;20(7):751-766. doi: 10.1080/14712598.2020.1739643. Epub 2020 Mar 20.
6
Towards a new avenue for producing therapeutic proteins: Microalgae as a tempting green biofactory.迈向生产治疗性蛋白的新途径:微藻作为诱人的绿色生物工厂。
Biotechnol Adv. 2020 May-Jun;40:107499. doi: 10.1016/j.biotechadv.2019.107499. Epub 2019 Dec 18.
7
Microalgae with Immunomodulatory Activities.具有免疫调节活性的微藻。
Mar Drugs. 2019 Dec 18;18(1):2. doi: 10.3390/md18010002.
8
Cell Encapsulation Within Alginate Microcapsules: Immunological Challenges and Outlook.海藻酸盐微胶囊内的细胞封装:免疫学挑战与展望
Front Bioeng Biotechnol. 2019 Dec 3;7:380. doi: 10.3389/fbioe.2019.00380. eCollection 2019.
9
Towards a biotechnological platform for the production of human pro-angiogenic growth factors in the green alga Chlamydomonas reinhardtii.迈向在绿藻莱茵衣藻中生产人类促血管生成生长因子的生物技术平台。
Appl Microbiol Biotechnol. 2020 Jan;104(2):725-739. doi: 10.1007/s00253-019-10267-6. Epub 2019 Dec 10.
10
Encapsulation and Transplantation of Pancreatic Progenitor Cells.胰腺祖细胞的封装与移植
Methods Mol Biol. 2019;2029:93-102. doi: 10.1007/978-1-4939-9631-5_8.